Blutungskomplikationen während und nach Einsatz der Herz-Lungen-Maschine

• LITERATUR

• 1 Addonizio jr. V. P, Macarak J, Nicolaou K. C, Edmunds Jr L. H, Colman R. W. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation. Blood 53: 1033-1042 1979;
• 2 Addonizio jr. V. P, Smith J. B, Strauss III J. F, Colman R. W, Edmunds Jr L. H. Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator. J. Thorac. Cardiovasc. Surg. 79: 91-96 1980;
• 3 Addonizio jr. V. P, Strauss III J. F, Colman R. W, Edmunds Jr L. H. Effects of prostaglandin E₁ on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. J. Thorac. Cardiovasc. Surg. 77: 119-126 1979;
• 4 Addonizio V. P, Strauss III J. F, Macarak E. J, Colman R. W, Edmunds Jr L. H. Preservation of platelet number and function with prostaglandin E₁ during total cardiopulmonary bypass in rhesus monkeys. Surgery 83: 619-625 1978;
• 5 Bachmann F, McKenna R, Cole E. R, Najafi E. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 70: 76-85 1975;
• 6 Bachmann F, McKenna R, Whitaker B. Abnormale Thrombozytenfunktion nach Herzchirurgie mit extrakorporaler Zirkulation. Schweiz. Med. Wschr. 104: 1374-1375 1974;
• 7 Bianco C, Eden A, Cohn Z. A. The induction of macrophage spreading: Role of coagulation factors and the complement system. J. Exp. Med. 144: 1531-1544 1976;
• 8 Bick R. L. Alterations of hemostasis associated with cardiopulmonary bypass: Pathophysiology, prevention, diagnosis and management. Semin. Thromb. Hemostas. 03: 59-82 1976;
• 9 Bick R. L, Arbegast N, Crawford L. Hemostatic defects induced by cardiopulmonary bypass. Vase. Surg. 09: 228-243 1975;
• 10 Blombäck M, Norén I, Senning A. Coagulation disturbances during extracorporeal circulation and the postoperative period. Acta Chir. Scand 127: 433-445 1964;
• 11 Brash J. L. Hydrophobic polymer surfaces and their interaction with blood. Ann. NY. Acad. Sci. 283: 356-370 1977;
• 12 Brash J. L, Davidson V. J. Adsorption on glass and polyethylene from solutions of fibrinogen and albumin. Thromb. Res. 09: 249-259 1976;
• 13 Brismar B, Gullbring B, Oldsson P. Effects of stored and fresh blood transfusions on postoperative pulmonary function. Clinical study on patients following extracorporeal circulation in association with aortic valve surgery. Europ. Surg. Res. 10: 153-164 1978;
• 14 Brögli H. Der Mechanismus des sogenannten »Heparin-Rebound« nach extrakorporalem Kreislauf. Thromb. Diathes. Haemorrh. 13: 401-417 1965;
• 15 Büttner W, Popöv-Cenic S, Müller N, Kladetzky R. G. Neutralization of heparin after extracorporeal circulation. Anaesthesist. 24: 299-305 1975;
• 16 Bull B. S, Huse W. M, Brauer F. S, Korpmann R. A. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J. Thorac. Cardiovasc. Surg. 69: 685-689 1975;
• 17 Chesebro J. H, Clements J. P, Fu-ster V, Elveback L. R, Smith H. C, Bardsley W. T, Fey R. L, Holmes Jr D. R, Vlietstra E, Pluth J. R, Wallace R. B, Puga F. J, Orszulak T. A, Piehler J. M, Schaff H. V, Danielson G. K. A platelet-inhibitor-drug trial in coronary-artery bypass operations. Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. New Engl. J. Med. 307: 73-78 1982;
• 18 Cohen J. A. Activated clotting time method for control of heparin is reliable during cardiopulmonary bypass. Anesthesiology 60: 121-124 1984;
• 19 Cohen L. H, Fosberg A. M, Anderson W. P, Collins Jr J. J. The effects of phlebotomy, hemodilution and autologous transfusion on systemic oxygenation and whole blood utilization in open-heart surgery. Chest 68: 283-295 1975;
• 20 Craddock P. R, Fehr J, Dalmasso A. P, Brigham K. L, Jacob H. S. Hemodialysis leukopenia: pulmonary vascular leucostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest 59: 879-888 1977;
• 21 Davey F. R, Parker F. B. Delayed hemostatic changes following cardiopulmonary bypass. Amer. J. Med. Sci. 27H2: 171-178 1976;
• 22 Davies G. C, Sobel M, Salzman E. W. Elevated plasma fibrinopeptide A and thromboxane B₂ levels during cardiopulmonary bypass. Circulation 61: 808-814 1980;
• 23 De Vries S. E, von Creveld S, Croen P, Muller E, Wettermark M. Studies on the coagulation of the blood in patients treatment with extracorporeal circulation. Thromb. Diath. Haemorrh. 05: 426-431 1961;
• 24 da Silva Dias W, Eisele J. W, Lepton I. H. Complement as a mediator of inflammation. III. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C3. J. Exp. Med. 126: 1027-1048 1967;
• 25 Dierich M. P, Wilhelmi D, Till G. Essential role of surface-bound chemoattractant in leukocyte migration. Nature 270: 351-352 1977;
• 26 DiScipio R. G. The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology 45: 587-595 1982;
• 27 Ditter H, Heinrich D, Matthias F. R, Wagner W-L, Sellmann-Richter R, Hehrlein F. W. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of ß-thromboglobulin, platelet factor 4, thromboxane B₂, 6-keto-prostaglandin Fla and heparin. Thromb. Res. 32: 393-408 1983;
• 28 Dutton R. C, Edmunds Jr L. H, Hutchinson J. C, Roe B. B. Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters. J. Thorac. Cardiovasc. Surg. 67: 258-265 1974;
• 29 Edmunds jr. L. H, Ellison N, Colman R. W, Niewiarowski S, Rao A. K, Addonizio Jr V. P, Stephenson L. W, Edie R. N. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J. Thorac. Cardiovasc. Surg. 83: 805-812 1982;
• 30 Evans E. A, Wellington J. S. Emboli associated with cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 48: 323-330 1964;
• 31 Faichney A, Davidson K. G, Wheatley D. J, Davidson J. F, Walker I. D. Prostacyclin in cardiopulmonary bypass operations. J. Thorac. Cardiovasc. Surg. 84: 601-608 1982;
• 32 Friesen R. H, Clement A. J. Individual responses to heparinization for extracorporal circulation. J. Thorac. Cardiovasc. Surg. 72: 875-879 1976;
• 33 Götze O, Bianco C, Cohn Z. A. The induction of macrophage spreading by Factor B of the properdin system. J. Exp. Med. 149: 372-386 1972;
• 34 Goldsmith G. H, Saito H, Ratnoff O. S. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments. J. Clin. Invest 78: 54-60 1978;
• 35 Gollub S. Heparin rebound in open-heart surgery. Surg. Gynecol. Obstet. 124: 337-346 1967;
• 36 Griffin J. H. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII. Proc. Natl. Acad. Sci. USA. 75: 1998-2002 1978;
• 37 Griffin J. H, Cochrane C. G. Recent advances in the understanding of contact activation reactions. Sem. Thrombos. Hemost. 05: 254-273 1979;
• 38 Hallowell P, Bland J. H, Buckley M. J, Loewenstein E. Transfusion of fresh autologous blood in open-heart surgery: A method for reducing bank blood requirements. J. Thorac. Cardio vase. Surg. 64: 941-948 1972;
• 39 Harker L. A, Malpass T. W, Branson H. E, Hessel E. A, Slichter S. J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective a-granule release. Blood 56: 824-834 1980;
• 40 Harker L. A, Sherrill J, Slichter S. J. Platelet and fibrinogen consumption in man. New Engl. J. Med. 287: 999-1005 1972;
• 41 Hatano R, Yamada T, Tsukuura T, Sunamori M. A role of extracorporeal circuit in the post-perfusion thrombocytopenia: A scanning electron microscopy observation. Jpn. J. Surg. 05: 234-245 1975;
• 42 Heiden D, Mielke C. H, Rodvien R, Hill J. D. Platelets, hemostasis, and thromboembolism during treatment of acute respiratory insufficiency with extracorporeal membrane oxygenation. J. Thorac. Cardiovasc. Surg. 70: 644-655 1975;
• 43 Heimark R. L, Kurachi K, Fujikawa K, Davie E. W. Surface activation of blood coagulation, fibrinolysis and kinin formation. Nature 286: 456-560 1980;
• 44 Heinrich D, Simon W, Türschmann W, Wüsten B, Roka L, Hehrlein F. W. Veränderungen des Hämostasesystems unter den Bedingungen der extrakorporalen Zirkulation bei aortokoronaren Venenbypassoperationen. In: Mikrozirkulation und Prostaglandinstoffwechsel. G. Blümel, S. Haas (Hrsg.). Schattauer. Stuttgart; New York: 1981: 195-198.
• 45 Heinrich D, Thilo-Körner D. G. S, Roka L. Die Bedeutung des Gefäßendothels für die Regulation der Fibrinolyse. Drug. Res. 33: 1375-1378 1983;
• 46 Hennessy V. L, Hicks R. E, Niewia-rowski S, Edmunds L. H, Colman R. W. Function of human platelets during extracorporeal circulation. Amer. J. Physiol. 232: 622-628 1977;
• 47 Henson P. M, Hollister J. R, Musson R. A, Webster R. O, Spears P, Henson J. E, McCarthy K. M. Inflammation as a surface phenomenon: Initiation of inflammatory processes by surface-bound immunologic components. Adv. Inflam. Res. 01: 341-350 1979;
• 48 Hill J. D, Aguilar M. J, Baranco A, DeLanerolle P, Gerbode F. Neuropathological manifestations of cardiac surgery. Ann. Thorac. Surg. 07: 409-419 1969;
• 49 Holemans R, Vermylen C, Ver-straete M. Disappearence of factor V activity after incubation of plasma with heparin or heparinoids. Thromb. Diathes. Haemorrh. 04: 303-322 1960;
• 50 Housman L. B. Blood conservation during cardiopulmonary bypass. In: Pathophysiology and Techniques of Cardiopulmonary Bypass. Vol. 1. Utley J. R. (Ed.) Williams and Wilkins; Baltimore, London: 1982: 120-127.
• 51 Hoylaerts M, Rijken D. C, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J. Biol. Chem. 257: 2912-2919 1982;
• 52 Huglie T. E. Complement factors and inflammation: Effects of a-thrombin on components C3 and C5. In: Chemistry and Biology of Thrombin. Lundblad R. L, Fenton J. W, Mann K. G. (Eds.) Ann Arbor Science; Michigan: 1977: 345-360.
• 53 Hyun B. H, Pence R. E, Davila J. C, Butcher J, Custer R. P. Heparin rebound phenomenon in extracorporeal circulation. Surg. Gynecol. Obstet. 115: 191-198 1962;
• 54 Kaplan A. P, Castellino F. J, Collen D, Wiman B, Taylor Jr F. B. Molecular mechanisms of fibrinolysis in man. Thromb. Haemost. 39: 263-283 1978;
• 55 Levai de M. R, Hill J. D, Mielke C. H, Macur M. F, Gerbode F. Blood platelets and extracorporeal circulation. Kinetic studies on dogs on cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 69: 144-151 1975;
• 56 Longmore D. B, Bennett J. G, Gueirrara D, Smith M, Bunting S, Mon-cada S, Reed P, Read N. G, Vane J. R. Prostacyclin: A solution to some problems of extracorporeal circulation. Experiment in greyhounds. Lancet I: 1002-1005 1979;
• 57 Longemore D. B, Bennett J. G, Hoyle P. M, Smith M. A, Gregory A, Osivand T, Jones W. A. Prostacyclin administration during cardiopulmonary bypass in man. Lancet. I: 800-804 1981;
• 58 Marby C. D, Read R. C, Thompson B. W, Williams G. D, White H. J. Identification of heparin resistance during cardiac and vascular surgery. Arch. Surg. 114: 129-134 1979;
• 59 McKenna R, Bachmann F, Whittaker B, Gilson J. R, Weinberg M. The hemostatic mechanism after open-heart surgery. Frequency of abnormal platelet functions during and after extracorporeal circulation. J. Thorac, Cardiovasc. Surg. 70: 298-308 1975;
• 60 McKenzie F. N, Dhall D. P, Arfors K-E, Nordlund S, Mathson N. A. Blood platelet behaviour during and after open-heart surgery. Brit. Med. J. 02: 795-798 1969;
• 61 Malpass T, Hanson S. R, Savage B, Hessel E. A, Harker L. A. Prevention of aquired transient defect in platelet plug formation by infused prostacyclin. Blood 57: 736-740 1981;
• 62 Mammen E. F. Natural proteinase inhibitors in extracorporal circulation. Ann. N.Y. Acad. Sci. 146: 754-762 1968;
• 63 Mandle jr. R. J, Colman R. W, Kaplan A. P. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc. Natl. Acad. Sci. USA. 73: 4179-4183 1976;
• 64 Mandle jr. R. J, Kaplan A. P. Hageman factor substrates. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J. Biol. Chem. 252: 6097-6104 1977;
• 65 Mason K. G, Hall L. E, Lamoy R. E, Wright C. B. Evaluation of blood filters: Dynamics of platelets and platelet aggregates. Surgery 77: 235-240 1975;
• 66 Merill E. W, Salzman E. W. Properties of materials affecting the behavior of blood at their surfaces. In: Sawyer P. N, Kaplitt M. J. (Eds.): Vascular Grafts. Appleton-Century-Croffts. New York: 1978: 119-129.
• 67 Mielke C. H, de Levai M. R, Hill J. D, Macur M. F, Gerbode F. Drug influence on platelet loss during extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 66: 845-854 1973;
• 68 Moriau M, Masure R, Horlet A, Debeys C, Chalant C. Hemostasis disorders in open-heart surgery with extracorporeal circulation. Importance of the platelet function and heparin neutralization. Vox Sang. 32: 41-51 1977;
• 69 Müller N, Popov-Cenic S, Büttner W, Kladetzky R. G, Egli H. Studies of fibrinolytic and coagulation factors during open-heart surgery. II. Postoperative bleeding tendency and changes in the coagulation system. Thromb. Res. 07: 589-598 1975;
• 70 Müller-Eberhard H. J. Complement. Ann. Rev. Biochem. 44: 697-724 1975;
• 71 Mustard J. F, Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol. Rev. 23: 97-187 1970;
• 72 Naeye R. L. Thrombotic state after a hemorrhagic diathesis: a possible complication of therapy with epsilon aminocapronacid. Blood 19: 694-701 1962;
• 73 Nuutinen L. S, Mononen P. Dipyridamol and thrombocyte count in open-heart surgery. J. Thorac. Cardiovasc. Surg. 70: 707-711 1975;
• 74 Petschek H, Adamis D, Kantro-witz A. R. Stagnation flow thrombus formation. Trans. Am. Soc. Artif. Intern. Organs 14: 256-260 1968;
• 75 Porter J. M, Silver D. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 56: 869-878 1968;
• 76 Ratnoff O. D, Naff G. B. The conversion of Cls to Cl esterase by plasmin and trypsin. J. Exp. Med. 125: 337-358 1967;
• 77 Ratnoff O. D, Saito H. Amidolytic properties of single-chain activated Hageman factor. Proc. Natl. Acad. Sci. USA. 76: 1461-1463 1979;
• 78 Roche J. K, Stengele J. M. Open-heart surgery and the demand for blood. JAMA. 225: 1516-1521 1973;
• 79 Rossi-Ferrini P. Coagulation problems related to open-heart surgery. Int. Anesthesiol. Clin. 14: 103-122 1976;
• 80 Salzman E. W. Nonthrombogenic surfaces: Critical review. Blood 38: 509-523 1971;
• 81 Sandiford F. M, Chiarello L, Hallman G. L, Cooley D. A. Aorto-coronary bypass in Jehovah’s Witnesses: Report of 36 patients. J. Thorac. Cardiovasc. Surg. 68: 1-7 1974;
• 82 Schaff H. V, Hauer J. M, Bra-wiey R. K. Auto transfusion in cardiac surgical patients after operation. Surgery 84: 713-718 1978;
• 83 Signori E. E, Penner J. A, Kahn D. R. Coagulation defects and bleeding in open-heart surgery. Ann. Thorac. Surg. 08: 521-529 1969;
• 84 Solis R. T, Noon G. P, Beall Jr A. C, DeBakey M. E. Particulate microembolism during cardiac operation. Ann. Thorac. Surg. 17: 332-344 1974;
• 85 Taubman S. B, Lepow I. H. Cleavage of human Cls by human lysosomal enzymes, plasmin, and trypsin. Immunochemistry 08: 951-961 1971;
• 86 Tector A. J, Gabriel R. P, Mate-ricka W. E, Oparah S. S, Flemm R. J, Lepley Jr D. Reduction of blood usage in open-heart surgery. Chest 70: 454-457 1976;
• 87 Thompson R. E, Mandle Jr R. J, Kaplan A. P. Association of factor XI and high-molecular-weight kininogen in human plasma. J. Clin. Invest 60: 1376-1380 1977;
• 88 Venerröd A. M, Laake K. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma. Thromb. Res. 08: 519-522 1976;
• 89 Verska J. J, Lonser E. R, Brewer L. A. Predisposing factors and management of hemorrhage following open-heart surgery. J. Cardiovasc. Surg. 13: 361-368 1972;
• 90 Vroman L, Adams A. L. Identification of rapid changes at plasma-solid interfaces. J. Biomed. Mater. Res. 03: 43-67 1969;
• 91 Vroman L, Adams A. L, Klings M. Interactions among human blood proteins at interfaces. Fed. Proc. 30: 1494-1502 1971;
• 92 Wagstaffe J. G, Clarke A. D, Jackson P. W. Reduction of blood loss by restoration of platelet levels using fresh autologous blood after cardiopulmonary bypass. Thorax. 27: 410-414 1972;
• 93 Walker J. D, Davidson J. F, Faich-ney A, Wheatley D. J, Davidson K. G. A double blind study of prostacyclin in cardiopulmonary bypass surgery. Brit. J. Haematol. 49: 415-423 1981;
• 94 Wandall H. H, Silvertsen U. The puzzle of blood platelets in extracorporeal circulation. Comments based on recirculation experiments. Scand. J. Thorac. Cardiovasc. Surg. 09: 140-143 1975;
• 95 Watkins W. D, Peterson W. B, Kong D. L, Kono K, Buckley M. J, Levine F. H, Philbin D. M. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow. J. Thorac. Cardiovasc. Surg. 84: 250-256 1982;
• 96 Webster R. O, Zanolari B, Henson P. M. Neutrophil chemotaxis in response to surface-bound human C5a. Exp. Cell. Res. 129: 55-62 1980;
• 97 Wiggins R. C, Bouma B. N, Cochrane C. G, Griffin J. H. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc. Natl. Acad. Sci. USA. 74: 4636-4640 1977;
• 98 Wiggins R. C, Giclas P. C, Henson P. M. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J. Exp. Med. 153: 1391-1404 1981;
• 99 Yeh jr. T, Shelton L, Yeh T. J. Blood loss and bank blood requirement in coronary bypass surgery. Ann. Thorac. Surg. 26: 11-16 1978;
• 100 Young J. A, Kisker C. T, Doty D. B. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann. Thorac. Surg. 26: 231-240 1978;